11C-methionine (MET) PET/MR for differentiation between tumor progression and treatment related changes for brain tumors after radiotherapy

Conclusions: Overall, integrated 11C-MET PET/MR had better diagnostic performance compared with contrast-enhanced MR. Multiple parameters such as SUVmax, T/N, CBF ratio and MRS were valuable for the differentiation between tumor progression and treatment related changes for brain tumors after radiotherapy.

Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Li, C., Hu, F., Zhang, X., Ruan, W., Liu, F., Lan, X. Tags: Head and Neck Source Type: research